Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes well beyond the annotations, detailing exactly what identifiers are returned (CIK, ticker, LEI, FIGI, RxCUI), how ownership data is included, that ISINs resolve to legal entities, and that LEI/FIGI enrichment degrades gracefully when upstream services are unavailable. It also discloses the internal cascading lookup behavior, which is useful context for an agent deciding whether to call this tool.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense and front-loaded with purpose, but it is overwrought: a long list of example queries and deeply nested parentheticals make it harder to scan than necessary. Every part contributes value, but the structure is not concise enough for an agent to parse quickly.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a lookup tool with no output schema, the description covers inputs, supported types, returned fields, edge cases like non-equity instruments, and failure degradation. The main gap is that it does not state explicitly what happens when a name cannot be resolved at all, leaving the agent to guess whether it returns null, an error, or an unresolved list.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds substantial meaning by showing example values for both type and value, explaining the difference between company and drug inputs, and warning that the entity name must be passed exactly as printed without trailing security-class words. This is exactly the kind of operational guidance that prevents failed lookups.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool resolves user-spoken names to canonical/official identifiers, names the supported types (company, drug), and gives concrete example queries. It distinguishes itself from sibling tools by noting that the IDs it returns are what other tools require as input and by telling the agent to use it first when a name but no ID is available.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID,' which gives a strong, actionable trigger condition. It also explains that it replaces 2-3 manual lookups and covers entities like bonds that other tools might miss, though it does not name specific sibling tools or provide explicit when-not-to-use scenarios.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

ask_pipeworx_beta is explicitly stated to be currently identical to ask_pipeworx, which is a direct duplication. The polymarket cluster (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_fill_risk, polymarket_edge_tracker, polymarket_kalshi_spread) has heavily overlapping purposes around finding and validating betting edges, and the ask_pipeworx / ask_pipeworx_grounded / deep_research / validate_claim tools all handle natural-language 'look up X' queries, making misselection likely without reading lengthy descriptions.

Naming Consistency4/5

snake_case is uniform and helpful prefixes (mbta_, polymarket_, pipeworx_, ask_pipeworx) create recognizable families. However, verb style is inconsistent — imperative verbs like ask/compare/discover/validate mix with noun-first names like bet_research, entity_profile, and search_within, and the memory trio (remember/recall/forget) doesn't share a common prefix.

Tool Count2/5

At 35 tools this exceeds the comfortable range, and the count is inflated by near-duplicates (ask_pipeworx_beta) and a dense 6-tool polymarket family. The server also mixes unrelated domains — only 4 of 35 tools are MBTA transit tools while the rest are Pipeworx data research, prediction markets, memory, and subscriptions — making it a kitchen sink rather than a well-scoped set.

Completeness4/5

The Pipeworx research surface is thorough: query, grounded verification, deep research, entity resolution, profiles, comparisons, change feeds, claim validation, and subscriptions are all covered with few dead ends. Minor gaps exist — the MBTA portion lacks schedule/line-detail tools beyond departures and alerts, and the AI-visibility feature feels bolted on without deeper integration.